Interim Report Q3 2012

JANUARY 1–SEPTEMBER 30, 2012 (compared with the same period a year ago)
The packaging operations that were divested on June 30, 2012, are reported for
the current and preceding year only as a separate line item in the income
statement – Net profit for the period from disposal group. Comments in this
report are thus entirely exclusive of the packaging operations.

The formation of a joint venture in Australia/New Zealand through the sale of
50% of the shares and a deconsolidation of the operations from the start of the
year constitutes the divestment that is referred to in this report. Figures for
the preceding year have not been recalculated.

  · Net sales rose 3% (8% excluding exchange rate effects and divestments) to
SEK 61,963m (60,402)
  · Operating profit excluding items affecting comparability rose 11% (13%
excluding exchange rate effects and divestments) to SEK 6,224m (5,599)
  · Items affecting comparability amounted to SEK -1,441m (-152)
  · Earnings per share were SEK 4.09 (5.66)
  · Cash flow from current operations was SEK 5,607m (3,802)

(Table included in attached pdf)

CEO’S COMMENTS
The acquisition of Georgia-Pacific's European tissue business was completed in
July. The acquisition strengthens our product offering and geographic presence
in Europe and will generate substantial synergies. The business has developed in
line with or slightly better than the projections in the acquisition plan.

In accordance with our strategy to focus on more highly refined products in the
publication papers business, in October we divested our 50% shareholding in
Aylesford Newsprint, and during the same month we completed the upgrade of a
newsprint machine in Sweden.

The hygiene operations are showing favorable growth and earnings performance.
For Forest Products, weak demand, low prices and a strengthened Swedish krona
have had a negative impact on profitability.

Consolidated net sales for the first nine months of 2012, excluding exchange
rate effects and the divestment, increased by 8% compared with the same period a
year ago. Net sales increased for the Personal Care and Tissue businesses by 11%
and 12%, respectively, excluding exchange rate effects and the divestment in
Australia/New Zealand. For Forest Products, net sales fell 7%. Operating profit
excluding exchange rate effects, the divestment and items affecting
comparability rose 13%. The Group's operating cash flow increased to SEK 7,198m
(5,326), mainly owing to a lower level of tied up working capital, and a higher
operating surplus.

Consolidated net sales for the third quarter of 2012, excluding exchange rate
effects and the divestment, increased by 16% compared with the third quarter of
2011. Most of the increase is attributable to the acquisition of the tissue
business in Europe and favorable sales performance for both the Personal Care
and Tissue operations. Operating profit excluding exchange rate effects, the
divestment and items affecting comparability rose 20%. Profit for Personal Care
and Tissue rose 23% and 58%, respectively, while profit for Forest Products fell
57%.


For further information, please contact:
Johan Karlsson, Vice President Investor Relations, +46 8 788 51 30
Petter Tiger, Acting Communications Manager Media Relations, +46 8 788 53 62


NB
SCA discloses the information provided herein pursuant to the Securities Markets
Act. This report has been prepared in both Swedish and English versions. In case
of variations in the content between the two versions, the Swedish version shall
govern. Submitted for publication on October 18, 2012, at 08.00 CET. This report
has not been reviewed by the company's auditors.